Gilead Sciences, Inc.

GILD·NASDAQ·$133.73Share Price as of 11/2·$166BMarket Cap as of 11/2

Financials

10-QQ3 ended 09/30/2610/30/26 10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202502/24/26 10-QQ3 ended 09/30/2511/07/25

Disclosures

8-KCurrent report10/29/26 8-KCurrent report08/04/26 8-KCurrent report05/20/26 8-KCurrent report05/07/26 8-KCurrent report05/04/26

Prospectuses and Registrations

S-3ASRAutomatic shelf registration08/06/26 424B5Prospectus supplement05/18/26 424B5Prospectus supplement05/14/26 FWPFree writing prospectus05/14/26 S-8Registration of securities for employees05/07/26

Proxies

DEF 14ADefinitive proxy03/20/26 DEFA14AAdditional proxy materials03/20/26 PX14A6GLetter to shareholders04/07/25 DEF 14ADefinitive proxy03/27/25 DEFA14AAdditional proxy materials03/27/25

Ownership

144Proposed sale of securities10/30/26 Form 4Insider transaction10/16/26 Form 4Insider transaction10/16/26 144Proposed sale of securities10/15/26 144Proposed sale of securities10/15/26

Other

N-PXAnnual report of proxy voting record08/26/26 SC TO-T/ASC TO-T/A04/17/26 SC TO-T/ASC TO-T/A04/01/26 ARSAnnual report to shareholders03/20/26 SC TO-TThird party tender offer03/06/26